(Q34571252)

3 August 2017

title

Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey (English)

1 reference

3 August 2017

main subject

cardiovascular disease

1 reference

Corrigendum to: ‘Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey’ [Eur Heart J (2011) 32 (4): 437-442; doi:10.1093/eurheartj/ehq438]

inferred from title

corrigendum / erratum

0 references

4

Mika Kivimaki

0 references

Mark Hamer

object named as

Mark Hamer

series ordinal

1

0 references

author name string

G David Batty

series ordinal

2

1 reference

3 August 2017

Adrie Seldenrijk

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

30 November 2010

1 reference

3 August 2017

published in

European Heart Journal

1 reference

3 August 2017

volume

32

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

437-442

1 reference

Anti-depressant medication use and C-reactive protein: results from two population-based studies

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women's Ischemia Syndrome Evaluation (WISE) study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

National patterns in antidepressant medication treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Psychiatric hospital admissions, behavioral risk factors, and all-cause mortality: the Scottish health survey

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Antidepressant use, depression, and survival in patients with heart failure

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

No health without mental health

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Weight gain in the treatment of mood disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038336

Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ438

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ438

Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ438

Antidepressants and cardiovascular outcomes in patients without known cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ438

Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ438

The validity of two versions of the GHQ in the WHO study of mental illness in general health care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ438

Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ438

Antidepressive treatment as a modulator of inflammatory process in patients with heart failure: effects on proinflammatory cytokines and acute phase protein levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ438

Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents

21 January 2018

1 reference

12 December 2020

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease

1 reference

12 December 2020

Antidepressant therapy and C-reactive protein levels

1 reference

12 December 2020

Specific Serotonin Reuptake Inhibition in Major Depressive Disorder Adversely Affects Novel Markers of Cardiac Risk

1 reference

12 December 2020

Identifiers

DOI

10.1093/EURHEARTJ/EHQ438

1 reference

3 August 2017

1 reference

3 August 2017

1 reference